Insulin Resistance: A Physician-Reviewed Guide

Definition

What Is Insulin Resistance?

Insulin is the hormone that signals cells to take up glucose from the bloodstream and to store nutrients. In insulin resistance, muscle, liver, and fat cells respond to that signal less efficiently. The pancreas compensates by producing more insulin — sometimes 5–10 times the normal amount — to keep fasting glucose in range. This compensatory hyperinsulinemia is itself biologically active: it promotes fat storage, suppresses fat release, drives sodium retention and hypertension, and stimulates ovarian androgen production in women.

Crucially, insulin resistance is present for years — often a decade or more — before fasting glucose or A1c rises into the prediabetic or diabetic range. By the time the standard glucose-based diagnosis is made, the underlying disease is well established. This is why fasting insulin and HOMA-IR are increasingly used by physicians focused on prevention, longevity, and metabolic health.

Diagnosis

How Is Insulin Resistance Diagnosed?

There is no single perfect test. Physicians use a panel:

• ·Fasting insulin (optimal generally <7 μIU/mL; insulin resistance suggested >10).
• ·HOMA-IR (fasting glucose × fasting insulin / 405); values >2.0 suggest insulin resistance, >2.5 are confirmatory.
• ·Hemoglobin A1c — normal <5.7%, prediabetes 5.7–6.4%, diabetes ≥6.5% [1].
• ·Fasting glucose — normal <100 mg/dL, prediabetes 100–125, diabetes ≥126.
• ·Triglyceride-to-HDL ratio — a TG/HDL >3 (mg/dL) is a strong proxy for insulin resistance in non-diabetic patients.
• ·Waist circumference — >35 inches in women, >40 inches in men, as a marker of visceral adiposity.
• ·Liver enzymes (ALT, AST), uric acid, and ApoB — frequently elevated in insulin resistance.

A 2-hour oral glucose tolerance test (OGTT) with insulin levels is the most sensitive test and can identify resistance years before A1c rises, but is rarely run in routine primary care.

Causes

What Causes Insulin Resistance?

Insulin resistance is multifactorial. The major drivers are:

• ·Visceral adiposity. Fat accumulated around abdominal organs is metabolically active and secretes inflammatory cytokines that directly impair insulin signaling.
• ·Genetics. Family history of type 2 diabetes substantially increases risk; insulin sensitivity is partly inherited.
• ·Sedentary behavior and low muscle mass. Skeletal muscle is the largest site of glucose disposal; less muscle and less contraction-driven glucose uptake mean more circulating glucose and insulin.
• ·Ultra-processed, refined-carbohydrate diets. Repeated post-meal glucose and insulin spikes drive long-term resistance.
• ·Chronic sleep deprivation. Even one week of restricted sleep measurably reduces insulin sensitivity in healthy adults.
• ·Chronic stress and elevated cortisol. Cortisol opposes insulin, raising blood glucose and promoting visceral fat storage.
• ·PCOS. Insulin resistance is a core feature and drives the hyperandrogenism, irregular cycles, and infertility of PCOS.
• ·Certain medications: corticosteroids, some antipsychotics, beta-blockers, statins (modestly), and HIV protease inhibitors.

Risks

Why Insulin Resistance Matters: Metabolic Syndrome, Prediabetes, and Type 2 Diabetes Risk

Insulin resistance sits upstream of the most common chronic diseases in adults. The progression is well characterized: insulin resistance → metabolic syndrome → prediabetes → type 2 diabetes → cardiovascular and microvascular complications.

Metabolic syndrome — diagnosed when three of five criteria are met (elevated waist circumference, triglycerides ≥150, HDL <40 men/<50 women, blood pressure ≥130/85, fasting glucose ≥100) — affects roughly one in three U.S. adults and roughly doubles cardiovascular disease risk and triples type 2 diabetes risk [2].

Roughly 38% of U.S. adults have prediabetes, and ~80% are unaware of it [1]. Without intervention, 5–10% of patients with prediabetes progress to type 2 diabetes each year.

Beyond diabetes, insulin resistance drives non-alcoholic fatty liver disease (now MASLD), is a strong independent risk factor for cardiovascular events, contributes to Alzheimer's disease pathophysiology (sometimes called "type 3 diabetes"), and impairs fertility in both sexes.

Treatment

How Is Insulin Resistance Reversed?

Insulin resistance is reversible — often dramatically so — with targeted treatment.

• ·Resistance training. Skeletal muscle is the largest insulin-sensitive tissue. Two to three sessions per week of progressive resistance training improve insulin sensitivity within weeks, independent of weight change.
• ·Aerobic activity. 150–300 minutes per week of moderate aerobic exercise, especially when paired with post-meal walking, lowers fasting insulin and improves glucose tolerance.
• ·Nutrition. A Mediterranean-style, lower-carbohydrate, or time-restricted eating pattern reduces post-meal glucose excursions. Protein-forward meals (~30–40 g protein) blunt post-meal insulin response and preserve lean mass.
• ·Sleep and stress. Restoring 7–9 hours of sleep and addressing chronic stress measurably improves insulin sensitivity.
• ·Weight loss. A 5–10% reduction in body weight improves insulin sensitivity meaningfully; 15% can normalize it. The landmark Diabetes Prevention Program showed a 58% reduction in progression to type 2 diabetes with ~7% lifestyle-induced weight loss [3].
• ·Pharmacotherapy. Metformin remains first-line for high-risk prediabetes. GLP-1 and dual-incretin agonists (semaglutide, tirzepatide) improve insulin sensitivity directly and through weight loss, with average reductions of 15–22.5% body weight in trials [4][5]. Inositol, berberine, and SGLT2 inhibitors are used in specific contexts under physician guidance.

Clinical Care

When to See a Physician

Consider a metabolic workup if you have a family history of type 2 diabetes; central adiposity; PCOS; gestational diabetes history; fatty liver on imaging; difficulty losing weight; or persistent fatigue and post-meal sluggishness.

Ask specifically for fasting insulin and HOMA-IR — not only A1c and fasting glucose. Standard panels miss insulin resistance in its earliest, most reversible stage.

Care is best delivered by a physician board-certified in obesity medicine (ABOM), endocrinology, or a concierge/longevity physician who tracks metabolic markers over time. Haute MD's Weight Loss directory features physicians who treat insulin resistance as the upstream lever it is — not just as a number on a lab report.